On a quiet day for the market, these stocks posted solid gains. Find out why.
News & Analysis: Mead Johnson Nutrition
The baby formula maker could be going the way of some its rivals and is in talks for a major buyout -- and that's welcome news for investors.
You probably haven't heard of all three of these names, but they're “Warren Buffett stocks" -- they belong to companies with sustainable competitive advantages, and they're fairly priced.
The change to China's one-child policy was expected to be a major growth event for these infant formula companies. A year later, here's how that bet has turned out.
These stocks stood out on another relatively calm day for the market. Find out why.
The baby-formula specialist surged on news of a potential takeover. Here's what you need to know.
Consumer staples stocks have generally outperformed the S&P 500 so far in 2016. Here are three of our analysts' current favorites.
Mead Johnson Nutrition, Altria, and Apple: three dividend stocks that are wealth-compounding machines.
SEC investigations raise new concerns about the baby formula maker.
Abbott Laboratories has been independent from its AbbVie spinoff for more than a year now, and its nutrition and diagnostics segments have given it plenty of growth.